ARPU per woman under Volpara®Enterprise™ software in the United States ranged from US$1.31 to US$5.52
Potential for continued revenue growth as it is looking at expanding its offering in the lung cancer screening sector, where it has a presence in following its recent US acquisition.
However, significant potential for growth and a success LT